Paltac（PCCO.F）株式概要株式会社Paltacは日本で化粧品、日用品、一般用医薬品の卸売りを行っている。 詳細PCCO.F ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長1/6過去の実績1/6財務の健全性6/6配当金3/6報酬当社が推定した公正価値より12.8%で取引されている 収益は年間4.29%増加すると予測されています 過去 1 年間で収益は4.2%増加しましたリスク分析株式の流動性は非常に低い すべてのリスクチェックを見るPCCO.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW479,582 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA479,582 investors already sharing narrativesYour Fair ValueUS$Current PriceUS$42.0018.4% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture01t2016201920222025202620282031Revenue JP¥1.5tEarnings JP¥25.9bAdvancedSet Fair ValueView all narrativesPaltac Corporation 競合他社GigaCloud TechnologySymbol: NasdaqGM:GCTMarket cap: US$1.4bGold.comSymbol: NYSE:GOLDMarket cap: US$1.2bLKQSymbol: NasdaqGS:LKQMarket cap: US$6.4bPoolSymbol: NasdaqGS:POOLMarket cap: US$7.1b価格と性能株価の高値、安値、推移の概要Paltac過去の株価現在の株価JP¥42.0052週高値JP¥42.0052週安値JP¥30.05ベータ0.0341ヶ月の変化0%3ヶ月変化n/a1年変化n/a3年間の変化n/a5年間の変化n/aIPOからの変化38.98%最新ニュースお知らせ • Jul 14Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)お知らせ • Jul 08MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. As of June 19, 2026, S.T. Corporation has resolved to tender its 339,000 shares. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation. MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders on July 7, 2026. A total of 24,466,104 shares were tendered, which was above the minimum number of shares to be purchased (8,676,100 shares). MediPal Holdings Corporation plans to implement a series of procedures to make the Tender Offeror the sole shareholder of Paltac Corporation (the “Squeeze-out Procedures”). Upon completion, the shares of Paltac Corporation will be delisted from the Prime Market of the Tokyo Stock Exchange.お知らせ • Jun 19Paltac Corporation Announces Management ChangesPaltac Corporation announced that, at a meeting of the Board of Directors held on June 19, 2026, it resolved to make changes in its directors and executive officers. Masahiro Noma was redesignated from Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters to Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters, General Manager of Logistics Headquarters. Masashi Gotan retired from the position of Executive Officer, General Manager of Logistics Headquarters and was attached to the General Affairs Headquarters.お知らせ • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026お知らせ • May 12MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation.お知らせ • May 11Paltac Corporation, Annual General Meeting, Jun 19, 2026Paltac Corporation, Annual General Meeting, Jun 19, 2026.最新情報をもっと見るRecent updatesお知らせ • Jul 14Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)お知らせ • Jul 08MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. As of June 19, 2026, S.T. Corporation has resolved to tender its 339,000 shares. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation. MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders on July 7, 2026. A total of 24,466,104 shares were tendered, which was above the minimum number of shares to be purchased (8,676,100 shares). MediPal Holdings Corporation plans to implement a series of procedures to make the Tender Offeror the sole shareholder of Paltac Corporation (the “Squeeze-out Procedures”). Upon completion, the shares of Paltac Corporation will be delisted from the Prime Market of the Tokyo Stock Exchange.お知らせ • Jun 19Paltac Corporation Announces Management ChangesPaltac Corporation announced that, at a meeting of the Board of Directors held on June 19, 2026, it resolved to make changes in its directors and executive officers. Masahiro Noma was redesignated from Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters to Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters, General Manager of Logistics Headquarters. Masashi Gotan retired from the position of Executive Officer, General Manager of Logistics Headquarters and was attached to the General Affairs Headquarters.お知らせ • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026お知らせ • May 12MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation.お知らせ • May 11Paltac Corporation, Annual General Meeting, Jun 19, 2026Paltac Corporation, Annual General Meeting, Jun 19, 2026.お知らせ • May 10Paltac Corporation to Report Fiscal Year 2026 Results on May 11, 2026Paltac Corporation announced that they will report fiscal year 2026 results on May 11, 2026お知らせ • Dec 02Paltac Corporation to Report Q3, 2026 Results on Feb 06, 2026Paltac Corporation announced that they will report Q3, 2026 results on Feb 06, 2026お知らせ • Sep 02Paltac Corporation to Report Q2, 2026 Results on Nov 04, 2025Paltac Corporation announced that they will report Q2, 2026 results on Nov 04, 2025株主還元PCCO.FUS Retail DistributorsUS 市場7D0%1.5%-1.4%1Yn/a-19.8%16.4%株主還元を見る業界別リターン: PCCO.FがUS Retail Distributors業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: PCCO.F US市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is PCCO.F's price volatile compared to industry and market?PCCO.F volatilityPCCO.F Average Weekly Movementn/aRetail Distributors Industry Average Movement8.1%Market Average Movement7.1%10% most volatile stocks in US Market16.3%10% least volatile stocks in US Market3.2%安定した株価: PCCO.Fの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のPCCO.Fのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト1928n/aTakuya Yoshidawww.paltac.co.jp株式会社Paltacは日本で化粧品、日用品、一般用医薬品の卸売業を営んでいる。同社は1898年に設立され、本社は大阪にある。株式会社Paltacは株式会社メディパルホールディングスの子会社である。もっと見るPaltac Corporation 基礎のまとめPaltac の収益と売上を時価総額と比較するとどうか。PCCO.F 基礎統計学時価総額US$2.46b収益（TTM）US$135.04m売上高(TTM)US$7.59b18.2xPER（株価収益率0.3xP/SレシオPCCO.F は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計PCCO.F 損益計算書（TTM）収益JP¥1.24t売上原価JP¥1.13t売上総利益JP¥108.05bその他の費用JP¥86.02b収益JP¥22.03b直近の収益報告Mar 31, 2026次回決算日Aug 03, 2026一株当たり利益（EPS）363.17グロス・マージン8.73%純利益率1.78%有利子負債／自己資本比率0%PCCO.F の長期的なパフォーマンスは？過去の実績と比較を見る配当金1.9%現在の配当利回り33%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/23 20:12終値2026/05/11 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Paltac Corporation 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Oliver James Gray MatthewCLSAYumiko KaiIchiyoshi Research Institute Inc.Kyoichiro ShigemuraNomura Securities Co. Ltd.1 その他のアナリストを表示
お知らせ • Jul 14Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)
お知らせ • Jul 08MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. As of June 19, 2026, S.T. Corporation has resolved to tender its 339,000 shares. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation. MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders on July 7, 2026. A total of 24,466,104 shares were tendered, which was above the minimum number of shares to be purchased (8,676,100 shares). MediPal Holdings Corporation plans to implement a series of procedures to make the Tender Offeror the sole shareholder of Paltac Corporation (the “Squeeze-out Procedures”). Upon completion, the shares of Paltac Corporation will be delisted from the Prime Market of the Tokyo Stock Exchange.
お知らせ • Jun 19Paltac Corporation Announces Management ChangesPaltac Corporation announced that, at a meeting of the Board of Directors held on June 19, 2026, it resolved to make changes in its directors and executive officers. Masahiro Noma was redesignated from Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters to Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters, General Manager of Logistics Headquarters. Masashi Gotan retired from the position of Executive Officer, General Manager of Logistics Headquarters and was attached to the General Affairs Headquarters.
お知らせ • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026
お知らせ • May 12MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation.
お知らせ • May 11Paltac Corporation, Annual General Meeting, Jun 19, 2026Paltac Corporation, Annual General Meeting, Jun 19, 2026.
お知らせ • Jul 14Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)
お知らせ • Jul 08MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. As of June 19, 2026, S.T. Corporation has resolved to tender its 339,000 shares. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation. MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders on July 7, 2026. A total of 24,466,104 shares were tendered, which was above the minimum number of shares to be purchased (8,676,100 shares). MediPal Holdings Corporation plans to implement a series of procedures to make the Tender Offeror the sole shareholder of Paltac Corporation (the “Squeeze-out Procedures”). Upon completion, the shares of Paltac Corporation will be delisted from the Prime Market of the Tokyo Stock Exchange.
お知らせ • Jun 19Paltac Corporation Announces Management ChangesPaltac Corporation announced that, at a meeting of the Board of Directors held on June 19, 2026, it resolved to make changes in its directors and executive officers. Masahiro Noma was redesignated from Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters to Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters, General Manager of Logistics Headquarters. Masashi Gotan retired from the position of Executive Officer, General Manager of Logistics Headquarters and was attached to the General Affairs Headquarters.
お知らせ • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026
お知らせ • May 12MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation.
お知らせ • May 11Paltac Corporation, Annual General Meeting, Jun 19, 2026Paltac Corporation, Annual General Meeting, Jun 19, 2026.
お知らせ • May 10Paltac Corporation to Report Fiscal Year 2026 Results on May 11, 2026Paltac Corporation announced that they will report fiscal year 2026 results on May 11, 2026
お知らせ • Dec 02Paltac Corporation to Report Q3, 2026 Results on Feb 06, 2026Paltac Corporation announced that they will report Q3, 2026 results on Feb 06, 2026
お知らせ • Sep 02Paltac Corporation to Report Q2, 2026 Results on Nov 04, 2025Paltac Corporation announced that they will report Q2, 2026 results on Nov 04, 2025
